Delivery Order SPE2DB22D9367-SPE2DB25FSZ13
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on September 18, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,474.02 on August 5, 2025, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). The contract carries no set-aside designation and is set to be completed by August 6, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency responsible...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order, which is scheduled for completion by July 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without set-aside designation and represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 22, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 12, 2025, carries a firm fixed-price structure with an ultimate completion date of September 15, 2025, and was made without set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,266.28 by the Defense Logistics Agency on August 12, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14 units. The delivery order, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by August 13, 2025, and will be fulfilled from the company's Park Ridge...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ13Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of August 11, 2025, and involves no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The Defense Logistics Agency utilizes this IDC vehicle to streamline the procurement of branded and generic prescription drugs, biologics, and medical consumables to support the pharmaceutical supply needs of Department of Defense healthcare systems. DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain reflects its capability to deliver specialized medications such as Trikafta, a prescription treatment for cystic fibrosis, directly to military medical facilities. The company's consistent performance across its extensive federal contract portfolio demonstrates its reliability in supporting Defense Department healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/8/25 |